These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 24353132

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Enhanced antitumor effect of anti-tissue factor antibody-conjugated epirubicin-incorporating micelles in xenograft models.
    Yamamoto Y, Hyodo I, Koga Y, Tsumura R, Sato R, Obonai T, Fuchigami H, Furuya F, Yasunaga M, Harada M, Kato Y, Ohtsu A, Matsumura Y.
    Cancer Sci; 2015 May; 106(5):627-34. PubMed ID: 25711681
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Assessment of antitumor activity and acute peripheral neuropathy of 1,2-diaminocyclohexane platinum (II)-incorporating micelles (NC-4016).
    Ueno T, Endo K, Hori K, Ozaki N, Tsuji A, Kondo S, Wakisaka N, Murono S, Kataoka K, Kato Y, Yoshizaki T.
    Int J Nanomedicine; 2014 May; 9():3005-12. PubMed ID: 24971011
    [Abstract] [Full Text] [Related]

  • 5. NC-6300, an epirubicin-incorporating micelle, extends the antitumor effect and reduces the cardiotoxicity of epirubicin.
    Takahashi A, Yamamoto Y, Yasunaga M, Koga Y, Kuroda J, Takigahira M, Harada M, Saito H, Hayashi T, Kato Y, Kinoshita T, Ohkohchi N, Hyodo I, Matsumura Y.
    Cancer Sci; 2013 Jul; 104(7):920-5. PubMed ID: 23495762
    [Abstract] [Full Text] [Related]

  • 6. Improved anti-tumor activity of stabilized anthracycline polymeric micelle formulation, NC-6300.
    Harada M, Bobe I, Saito H, Shibata N, Tanaka R, Hayashi T, Kato Y.
    Cancer Sci; 2011 Jan; 102(1):192-9. PubMed ID: 21040218
    [Abstract] [Full Text] [Related]

  • 7. Synergistic antitumor effects of dasatinib and oxaliplatin in gastric cancer cells.
    Shi M, Lou B, Ji J, Shi H, Zhou C, Yu Y, Liu B, Zhu Z, Zhang J.
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):35-44. PubMed ID: 23712327
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience.
    Petrioli R, Francini E, Roviello F, Marrelli D, Fiaschi AI, Laera L, Rossi G, Bianco V, Brozzetti S, Roviello G.
    Cancer Chemother Pharmacol; 2015 May; 75(5):941-7. PubMed ID: 25743995
    [Abstract] [Full Text] [Related]

  • 17. Reinforcement of antitumor effect of micelles containing anticancer drugs by binding of an anti-tissue factor antibody without direct cytocidal effects.
    Takashima H, Koga Y, Tsumura R, Yasunaga M, Tsuchiya M, Inoue T, Negishi E, Harada M, Yoshida S, Matsumura Y.
    J Control Release; 2020 Jul 10; 323():138-150. PubMed ID: 32259544
    [Abstract] [Full Text] [Related]

  • 18. Enhanced antitumor activity and attenuated cardiotoxicity of Epirubicin combined with Paeonol against breast cancer.
    Wu J, Xue X, Zhang B, Cao H, Kong F, Jiang W, Li J, Sun D, Guo R.
    Tumour Biol; 2016 Sep 10; 37(9):12301-12313. PubMed ID: 27272157
    [Abstract] [Full Text] [Related]

  • 19. Phase II multicentre study of efficacy and feasibility of dose-intensified preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) in resectable gastroesophageal cancer.
    Jary M, Ghiringhelli F, Jacquin M, Fein F, Nguyen T, Cleau D, Nerich V, El Gani M, Mathieu P, Valmary-Degano S, Arnould L, Lassabe C, Lamfichekh N, Fratté S, Paget-Bailly S, Bonnetain F, Borg C, Kim S.
    Cancer Chemother Pharmacol; 2014 Jul 10; 74(1):141-50. PubMed ID: 24824852
    [Abstract] [Full Text] [Related]

  • 20. Biological characterization of folate-decorated biodegradable polymer-platinum(II) complex micelles.
    Wang R, Hu X, Wu S, Xiao H, Cai H, Xie Z, Huang Y, Jing X.
    Mol Pharm; 2012 Nov 05; 9(11):3200-8. PubMed ID: 22954154
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.